Datopotamab deruxtecan Biologics License Application accepted in US

eAwazMedicine

London – AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy. The Prescription Drug User Fee Act date, the Food and Drug Administration (FDA) action date for its …

Tagrisso shows great efficacy for patients with lung cancer

eAwazMedicine

First EGFR inhibitor and targeted treatment to demonstrate progression-free survival benefit in Stage III setting London – Positive high-level results from the LAURA Phase III trial showed AstraZeneca’s Tagrisso (osimertinib) demonstrated a statistically significant and highly clinically meaningful improvement in progression-free survival (PFS) for patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy …

Tagrisso shows survival in early-stage EGFR-mutated lung cancer

eAwazMedicine

London – Positive results from the ADAURA Phase III trial showed AstraZeneca’s Tagrisso (osimertinib) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), compared to placebo in the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumour resection with curative intent. These results will be …

AstraZeneca pills help lung cancer patients

eAwazMedicine

London – AstraZeneca has announced that its daily pill decreases deaths in lung cancer patients by half. The results were talked about at the American Society of Clinical Oncology in Chicago and published  in the New England Journal of Medicine. The medication, known as osimertinib and marketed as Tagrisso, targets a particular receptor that promotes the growth of cancer cells. …

4-time Stanley Cup champion Mike Bossy dies at 65

eAwazSports News

New York – Mike Bossy, one of hockey’s most prolific goal-scorers has died after a battle with lung cancer at 65 in Montreal. He was the New York Islanders’ star player during 1980s. The Islanders and TVA Sports, the French-language network in Canada where he worked as a hockey analyst, informed about Bossy’s death.